The Claim
In patients with non-obstructive coronary artery disease, statin use is not associated with differences in total plaque burden or low-attenuation plaque burden, and statins selectively alter plaque composition without changing overall plaque volume.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with non-obstructive coronary artery disease, statin use does not change the total amount of plaque or the amount of low-attenuation plaque, but it changes the makeup of the plaque without altering its overall volume.
See the scientific wording
In patients with non-obstructive coronary artery disease, statin use is not associated with differences in total plaque burden or low-attenuation plaque burden, indicating that statins may selectively affect plaque composition without altering overall plaque volume.
Statins lower cholesterol in the blood, which reduces fatty buildup inside artery walls. This causes the plaque to lose its soft, unstable core and instead become harder and more stable by accumulating calcium. The total amount of plaque does not change, but its structure does — dangerous soft plaque turns into safer hard plaque.
What the research says
1 studyStatins don’t make more or less plaque in the heart arteries, but they do turn the soft, dangerous kind into harder, safer kind — and this study shows that’s exactly what happens.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.